GlobalData
GlobalData

Rebecca Panks

  • Home
  • Author: Rebecca Panks

Merck’s Imago Biosciences acquisition to go head-to-head with GSK in increasingly competitive blockbuster market, says GlobalData

Following the news that Merck is to acquire Imago Biosciences, a clinical-stage biotech developing the lysine-specific demethylase 1 (LSD1) inhibitor bomedemstat for the treatment of myelofibrosis (MF); Sam Warburton, Oncology Analyst at GlobalData, a leading data and analytics company, offers his view: “Big pharma appears to be setting its sights on the relatively small but potentially […]
Read more

Radar absorbing materials maintainability a factor allowing B-21 Raider to take on US strategic bombing burden, says GlobalData

Following the unveiling of the B-21 Raider; Harry Boneham, Aerospace Analyst at GlobalData, a leading data and analytics company, offers his view on the potential of its use of next-generation radar absorbing technology: “One of the key features, and best kept secrets, of the B-21 Raider programme has been the introduction of the next-generation of […]
Read more

Removal of the Netherlands’ coal power generation cap due to Russia-Ukraine war a setback for country’s renewable transition, says GlobalData

The Netherlands’ decision to restructure its energy plans amid the Russia-Ukraine geopolitical crisis, combined with the scrapping of its nuclear phase out plans in 2021, is a setback for the country’s renewable power aspirations, says GlobalData, a leading data and analytics company. The Dutch government has lifted a cap on coal-based power generation, which was […]
Read more

NICE endometriosis guideline update is a positive step for diagnosis and surgical management, says GlobalData

Following the news that the National Institute of Health and Care Excellence (NICE) has agreed to update its guidelines on endometriosis diagnosis and surgical management when fertility is a priority; Amy Murray, Healthcare Analyst at GlobalData, a leading data and analytics company, offers her view: “The updated NICE guidelines on endometriosis marks the first such […]
Read more

Sports-related head injuries could expand indications of neurology markets, says GlobalData

Both amateur and professional footballers are at a higher risk of head injuries from high-impact head contact during training and gameplay. With the incidence of sports-related injury increasing, growth within neurological medical device markets can also be expected—with hydrocephalus shunts, interventional neuroradiology, and neuromodulation markets estimated to be worth $0.5 billion, $4.5 billion, and $10.7 […]
Read more

Sotatercept set to become leading therapy in PAH market, says GlobalData

Following the news that Merck reported positive top-line Phase III clinical trial results for its pulmonary arterial hypertension (PAH) pipeline drug, sotatercept; Kaya Olczak, Healthcare Analyst at GlobalData, a leading data and analytics company, comments: “Sotatercept has potential to fulfil a highly unmet need in the PAH space: the lack of a disease modifying therapy. […]
Read more

FIFA: Huge sponsorship revenue potential of $1.7 billion up for grabs but most brands priced out as sponsorship slots cost $63 million, says GlobalData

Heading into the opening weekend of the 2022 FIFA World Cup, the tournament is set to see 27 official brand sponsorship partners with prime marketing rights, says GlobalData, with a total of $1.7 billion estimated to be generated by sponsorships. However, the leading data and analytics company notes that these partnerships* come at a heavy […]
Read more

Arcutis’s roflumilast estimated to bring $80 million in sales by 2030 following promising clinical trial results, says GlobalData

Following the news that Arcutis Biotherapeutics announced that its roflumilast met its main endpoints in the Phase III trial INTEGUMENT-1 (NCT04773587) for atopic dermatitis (AD). Ramla Salad, Pharma Analyst at GlobalData, a leading data and analytics company, offers her view: “Following such a fantastic result, GlobalData expects Arcutis Biotherapeutics’ roflumilast to enter the US atopic […]
Read more

Estée Lauder, the second largest global beauty company*, will reap the benefits of acquiring Tom Ford in the long run, says GlobalData

Following the news that Estée Lauder will acquire designer fashion house Tom Ford for $2.8 billion; Lia Neophytou, Senior Health & Beauty Analyst at GlobalData, a leading data and analytics company, offers her view: “Estée Lauder, which was the second largest company in the global beauty* market last year according to GlobalData, has improved its […]
Read more

Global Powertrain Webinar invite: Electric vehicles face uphill struggle to maintain mass-market affordability, says LMC GlobalData

This Thursday, 17th November 2022 at 14:00 GMT, the LMC Powertrain team at GlobalData will host a webinar on the outlook for global powertrain and electrification. Click here to register, and find out: How the roadmaps of automakers and battery suppliers are driving demand for materials that the mining and chemicals sectors will struggle to […]
Read more

CAR-T therapy shows huge promise for treating CLL, but significant clinical challenges remain, says GlobalData

Despite a number of barriers and complications for autologous agents, there are a total 44 CAR-T* therapies in the pipeline for chronic lymphocytic leukemia (CLL), says GlobalData. Autologous CAR-T therapy is a patient-specific immunotherapy that involves the genetic modification of a patient’s own T cells to attack their cancer. However, this therapy is typically less […]
Read more

Novel technologies and therapies for Parkinson’s disease seeing greater interest by big pharma, says GlobalData

Due to the high-risk nature of drugs being developed for neurology diseases, most product launches in the recent history of Parkinson’s disease have been the result of strategic partnerships for marketing and sales, with few exceptions. Therefore, large pharmaceutical companies such as Merck, Roche, Novartis, and AbbVie often prefer to invest in therapies that are […]
Read more

ECG implants and smartwatches vital for early detection of heart failure and COVID-19 management, says GlobalData

Remote patient monitoring (RPM) devices with electrocardiographic (ECG) capabilities such as medically implantable monitors and more consumer-focused products such as AliveCor’s KardiaMobile 6L and Apple’s Series 4 and 5 represent the future of cardiac monitoring, according to GlobalData. The leading data and analytics company notes that these devices’ ability to track early heart damage and […]
Read more
1 2 3 4 5 77